Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction
- 1 August 1992
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 124 (2) , 305-314
- https://doi.org/10.1016/0002-8703(92)90591-i
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.Circulation, 1988
- Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: Controlled comparison with intracoronary streptokinaseJournal of the American College of Cardiology, 1988
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Preclinical Pharmacological Evaluation of Anisoylated Plasminogen Streptokinase Activator ComplexDrugs, 1987
- Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapyNature, 1981
- Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.Circulation, 1981
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980